We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Alliance Formed to Digitalize Medicine and Healthcare

By LabMedica International staff writers
Posted on 28 Jun 2017
Print article
Image: A new alliance has been formed with the goal of driving digitization in medicine and healthcare (Photo courtesy of PixelsTech).
Image: A new alliance has been formed with the goal of driving digitization in medicine and healthcare (Photo courtesy of PixelsTech).
The Universitätsklinikum Erlangen, Siemens Healthineers (Erlangen, Germany), the Friedrich-Alexander-Universität-Erlangen-Nürnberg (FAU), the Fraunhofer Institute for Integrated Circuits (IIS), and Medical Valley EMN have entered into an alliance to establish the Digital Health Innovation Platform (d.hip) with the aim of driving digitalization in medicine and healthcare.

Founded in 1815, the Universitätsklinikum Erlangen covers all the areas of modern medicine with its 24 departments, 19 independent departments, and 7 institutes, and uses the latest knowledge from medical research and state-of-the-art equipment. The FAU, founded in 1743, is one of the largest universities in Germany, with around 40,000 students, 263 degree programs, 4,000 academic staff in the sciences (including 576 professors), about 180 million euros (2016) in third-party funding, and 500 partnerships with universities around the world.

The Fraunhofer IIS is one of the world's leading application-oriented research institutions for microelectronic and IT system solutions and services. In close cooperation with partners and clients, it provides R&D services in various areas, including imaging systems and medical technology, among others. Medical Valley EMN e.V. has been operating as a cluster management organization since 2007 and currently comprises 190 members from the areas of business, academia, healthcare, networks, and politics. It undertakes a variety of functions, including the coordination of the “Digital Medicine/Health” platform as part of the Zentrum Digitalisierung Bayern (Bavarian Center for Digitalization), coordination of the “model region for digital healthcare management in Franconia” research initiative, and management of the “Digital Health Hub” as part of an initiative by the Federal Ministry for Economic Affairs. Siemens Healthineers, the separately managed healthcare business of Siemens AG, offers a comprehensive portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine.

The partners will be combining their medical, technical, and economical expertise to stimulate research into new areas and to conduct development so that it is even more interdisciplinary, clinically and scientifically relevant, and practice-oriented than ever. The platform will make it possible to implement innovations more efficiently and effectively, thereby reducing the time-to-market. The partners will also use their combined expertise to generate innovations. Among other things, machine learning will be used to render hospital procedures more efficient. For example, automated processes in clinical imaging can be tested that permit earlier diagnoses of breast cancer with a better detection rate. Methods for mathematical optimization and machine learning can help optimize the planning of operations, thus improving planning reliability.

Additionally, the partners see the integration of new technologies as having tremendous potential for improving medical care. “Clinical-grade wearables and sensor-based monitoring can promote a healthier lifestyle and improve treatment compliance or help to introduce adjustments to treatment early on. Intelligent image analysis methods for digital pathology can also support the selection and adjustment of individual treatments for tumor patients,” said Prof. Dr. Albert Heuberger, Director of the Fraunhofer Institute for Integrated Circuits IIS in Erlangen.

“Siemens Healthineers has committed itself to helping healthcare providers to overcome their current challenges and to continue their development in their particular business environment,” said Dr. Arthur Kaindl, General Manager of Digital Health Services, Siemens Healthineers. “We will contribute to d.hip our extensive expertise in the area of medical and laboratory technology and we want to make sure that our customers can use innovations in the field of digitalization as early as possible to improve medical patient care and reduce healthcare costs.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more